Abstract: A filter holder comprises: a plurality of filter frames disposed such that at least some thereof are adjacent to each other; and a folding member which supports filter frames, from among the plurality of filter frames, adjacent to each other so as to be rotatable with respect to each other. The folding member comprises: a folding part which has a predetermined thickness and is flexible so as to be foldable by means of rotation of the adjacent filter frames adjacent with respect to each other; and a plurality of edge parts which are connected to the respective sides of the folding part with the folding portion therebetween and rotate together with the adjacent filter frames, and wherein when viewed from a cross-section of the folding member, the edge parts may have a greater thickness than the folding part.

Abstract: An air filter comprises: a first filter frame in which a plurality of first chambers are formed; a second filter frame in which a plurality of second chambers are formed and which is arranged at the rear of the first filter frame; and a filter material which is accommodated in the plurality of first chambers and the plurality of second chambers to filter air, wherein the first filter frame and the second filter frame are arranged so that, when seen from the front, the center of each of the plurality of second chambers is out of line with the center of each of the plurality of first chambers, in the vertical direction.

Abstract: The present invention relates to stem cell-derived mature cardiomyocytes and a cardiovascular disease model using same and, more specifically, to differentiation into mature ventricular cardiomyocytes by culturing stem cells in a medium containing FGF4 and ascorbic acid, and use of the differentiated mature ventricular cardiomyocytes as a cardiovascular disease cell model. The mature ventricular cardiomyocytes, obtained by culturing stem cells in a medium containing FGF4 and ascorbic acid and inducing the differentiation thereof, and cardiovascular disease cell model using same according to the present invention are very useful for screening for cardiovascular disease therapeutic agents and evaluation of the toxicity of new drugs.

Abstract: A coil component is provided. The coil component includes a body having fifth and sixth surfaces opposing each other, first and second surfaces respectively connecting the fifth and sixth surfaces of the body and opposing each other, and third and fourth surfaces respectively connecting the first and second surfaces of the body and opposing each other in one direction, a recess disposed in an edge between one of the first and second surfaces of the body and the sixth surface of the body, a coil portion disposed inside the body and exposed through the recess, and an external electrode including a connection portion disposed in the recess and connected to the coil portion, and a pad portion disposed on one surface of the body. A length of the pad portion in the one direction is greater than a length of the connection portion in the one direction.

Abstract: Disclosed are an inverter control device and method. The method according to an embodiment of the present includes estimating a rotation speed of a motor, determining a slip frequency reference using an energy of a direct current terminal capacitor of an inverter, which provides an output voltage to the motor, and a direct current terminal energy reference when a direct current terminal voltage of the inverter is a certain level or less, and providing a frequency reference determined by adding the rotation speed of the motor and the slip frequency reference to the inverter.

Abstract: The present disclosure provides an inverter control device for estimating the magnetic flux of a rotor, and calculating and compensating for a slip frequency on the basis of a torque current and a magnetic flux current, to control the speed of an electric motor. To this end, the present invention may comprise: a command voltage generation unit for outputting a three-phase PWM voltage with respect to a command frequency to an inverter on the basis of voltage/frequency operation; and a slip frequency determination unit for determining a slip frequency on the basis of the phase current and phase voltage of an electric motor driven by the inverter.

Abstract: The present disclosure provides an inverter control device which estimates back electromotive force of an induction motor, and which uses a torque current and a flux current so as to calculate a slip frequency and compensate for same, thereby enabling the motor to operate at a constant speed. To this end, the present invention may comprise: a command voltage generating unit for outputting, to an inverter, a three phase PWM voltage with respect to a command frequency on the basis of a voltage/frequency operation; and a slip frequency determining unit for determining a slip frequency on the basis of a phase current and a phase voltage of a motor driven by the inverter.

Abstract: The present invention relates to a novel N-acylurea derivative and the use thereof for the prevention or treatment of cardiovascular disease, and more particularly to a novel N-acylurea derivative, a pharmaceutical composition for prevention or treatment of cardiovascular disease, which contains the N-acylurea derivative as an active ingredient, and a method of preparing the N-acylurea derivative. The N-acylurea derivative according to the present invention can inhibit platelet aggregation by inhibiting the activity of talin in the intracellular matrix, and thus can be useful for the prevention or treatment of cardiovascular disease.

Abstract: Disclosed are an inverter control device and method. The method according to an embodiment of the present includes estimating a rotation speed of a motor, determining a slip frequency reference using an energy of a direct current terminal capacitor of an inverter, which provides an output voltage to the motor, and a direct current terminal energy reference when a direct current terminal voltage of the inverter is a certain level or less, and providing a frequency reference determined by adding the rotation speed of the motor and the slip frequency reference to the inverter.

Abstract: The present invention relates to a novel N-acylurea derivative and the use thereof for the prevention or treatment of cardiovascular disease, and more particularly to a novel N-acylurea derivative, a pharmaceutical composition for prevention or treatment of cardiovascular disease, which contains the N-acylurea derivative as an active ingredient, and a method of preparing the N-acylurea derivative. The N-acylurea derivative according to the present invention can inhibit platelet aggregation by inhibiting the activity of talin in the intracellular matrix, and thus can be useful for the prevention or treatment of cardiovascular disease.

Abstract: The present disclosure provides an inverter control device which estimates back electromotive force of an induction motor, and which uses a torque current and a flux current so as to calculate a slip frequency and compensate for same, thereby enabling the motor to operate at a constant speed. To this end, the present invention may comprise: a command voltage generating unit for outputting, to an inverter, a three phase PWM voltage with respect to a command frequency on the basis of a voltage/frequency operation; and a slip frequency determining unit for determining a slip frequency on the basis of a phase current and a phase voltage of a motor driven by the inverter.

Abstract: The present disclosure provides an inverter control device for estimating the magnetic flux of a rotor, and calculating and compensating for a slip frequency on the basis of a torque current and a magnetic flux current, to control the speed of an electric motor. To this end, the present invention may comprise: a command voltage generation unit for outputting a three-phase PWM voltage with respect to a command frequency to an inverter on the basis of voltage/frequency operation; and a slip frequency determination unit for determining a slip frequency on the basis of the phase current and phase voltage of an electric motor driven by the inverter.

Abstract: Provided are a pouch for a secondary battery, which is capable of minimizing a folded area of a bridge part of the pouch that is manufactured by folding two accommodation parts to overlap each other, and a die for forming the pouch for the secondary battery. The pouch for the secondary battery includes a lower accommodation part accommodating an electrode assembly therein, an upper accommodation part covering an opening of the lower accommodation part, and a bridge part connecting the lower accommodation part to the upper accommodation part. When the lower accommodation part and the upper accommodation part are unfolded, a height of the bridge part, which is measured from a bottom surface of the lower accommodation part, is lower than that of the lower accommodation part, which is measured from the bottom surface of the lower accommodation part.

Abstract: Provided are a pouch for a secondary battery, which is capable of minimizing a folded area of a bridge part of the pouch that is manufactured by folding two accommodation parts to overlap each other, and a die for forming the pouch for the secondary battery. The pouch for the secondary battery includes a lower accommodation part accommodating an electrode assembly therein, an upper accommodation part covering an opening of the lower accommodation part, and a bridge part connecting the lower accommodation part to the upper accommodation part. When the lower accommodation part and the upper accommodation part are unfolded, a height of the bridge part, which is measured from a bottom surface of the lower accommodation part, is lower than that of the lower accommodation part, which is measured from the bottom surface of the lower accommodation part.

Abstract: The present invention relates to a novel N-acylurea derivative and the use thereof for the prevention or treatment of cardiovascular disease, and more particularly to a novel N-acylurea derivative, a pharmaceutical composition for prevention or treatment of cardiovascular disease, which contains the N-acylurea derivative as an active ingredient, and a method of preparing the N-acylurea derivative. The N-acylurea derivative according to the present invention can inhibit platelet aggregation by inhibiting the activity of talin in the intracellular matrix, and thus can be useful for the prevention or treatment of cardiovascular disease.

Abstract: Disclosed is an image encoder comprising: a basic layer processor for converting a first dynamic range image into a second dynamic range image, and encoding the second dynamic range image so as to generate a basic layer code stream; an inverse quantizer for inversely quantizing the second dynamic range image quantized by the basic layer processor, and deriving DCT domain data; and an enhancement layer processor for deriving DCT domain data for the first dynamic range image, and deriving a first dynamic range image-related prediction coefficient from DCT domain data for the second dynamic range image and the DCT domain data for the first dynamic range image. According to the present invention, encoding and decoding, using the correlation of the first dynamic range image data and the second dynamic image data, of an HDR image having JPEG backward-compatibility can be provided such that encoding and decoding performance can be improved.

Abstract: An inverter control device is disclosed. The device is configured: for determining a fundamental-wave magnitude of a phase-voltage corresponding to a modified voltage; for performing a proportional-integral (PI) operation of an error between the fundamental-wave magnitude of the phase-voltage and a magnitude of a reference voltage, and for outputting a compensation voltage; configured for adding the compensation voltage to the reference voltage to obtain an output; and for over-modulating the output and for outputting the over-modulated output as the modified voltage.

Abstract: An apparatus for controlling an inverter is disclosed. The apparatus for controlling the inverter contained in an inverter system configured to drive a motor determines a slip frequency to be used for compensation of a frequency of a first reference voltage, not only using a first reference voltage (including an amplitude and frequency) of the first reference voltage applied to the inverter, but also using an output current of the motor or a rotor speed of the motor. The apparatus determines not only a frequency of a second reference voltage obtained by compensation of the slip frequency, but also an amplitude of the second reference voltage corresponding to the frequency of the second reference voltage.

Abstract: An apparatus for controlling an inverter is disclosed. The apparatus for controlling the inverter contained in an inverter system configured to drive a motor determines a slip frequency to be used for compensation of a frequency of a first reference voltage, not only using a first reference voltage (including an amplitude and frequency) of the first reference voltage applied to the inverter, but also using an output current of the motor or a rotor speed of the motor. The apparatus determines not only a frequency of a second reference voltage obtained by compensation of the slip frequency, but also an amplitude of the second reference voltage corresponding to the frequency of the second reference voltage.

Abstract: The present disclosure relates to an inverter, and more specifically to an inverter that can be restarted stably by determining whether to restart it when power is supplied after a failure has occurred in the inverter due to a fault in the main supply.